Clinical Study
Erlotinib and Concurrent Chemoradiation in Pretreated NSCLC Patients: Radiobiological Basis and Clinical Results
Table 2
Treatment related toxicity.
| | | Grade 1-2 | Grade 3-4 |
| | Hematological | | Anemia | 41 (68%) | 3 (5%) | | White blood cell | 26 (43%) | 18 (30%) | | Platelet | 30 (50%) | 7 (12%) |
| | Nonhematological | | Esophagitis | 32 (55%) | 1 (2%) | | Pulmonary | 14 (23%) | 5 (8%) | | Rush | 39 (65%) | 4 (7%) | | Diarrhea | 10 (17%) | 3 (5%) | | Nausea | 9 (15%) | — | | Photophobia | 5 (8%) | — | | Hepatic enzymes | 30 (50%) | 8 (13%) | | Mucositis | 12 (20%) | — |
|
|
